Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Mutations in the Splicosome Lead to Alternative Splicing of CSF3R in Promoting Myelodysplastic Syndromes

Frances Austin, MD, Hrishikesh M Mehta, PhD, Seth J. Corey, MD MPH, Chonghui Cheng, MD PhD

Blood (2016) 128 (22): 3897.

https://doi.org/10.1182/blood.V128.22.3897.3897

Published: 2016

Journal Articles

Genetic Ablation of Sbds in Zebrafish Results in Neutropenia, Diminished Growth, and Reduced Viability, Indicating Its Roles in Embryonic and Post-Embryonic Development

Usua Oyarbide, PhD, Margaret J Kell, Javier Farinas, BS, Rachel Hartig, Jacek Topczewski, PhD, Seth J. Corey, MD MPH

Blood (2015) 126 (23): 3607.

https://doi.org/10.1182/blood.V126.23.3607.3607

Published: 2015

Journal Articles

Specific Gtpase Dynamin Isoforms Regulate Megakaryocyte Membrane Remodeling and The Formation Of Multivesicular Bodies and Microparticles

Yolande Chen, MD, Arinola Awomolo, MD, Jorie Aardema, BS, Michael Hession, Francisco Javier Gonzalez, MD, Hilary Christensen, Walter H. Kahr, MD, PhD, Seth J. Corey, MD, MPH

Blood (2013) 122 (21): 3529.

https://doi.org/10.1182/blood.V122.21.3529.3529

Published: 2013

Journal Articles

Profound Signaling Abnormalities Due to Cytoplasmic Variants of CSF3R in Patients with Myelodysplastic/Myeloproliferative Syndromes Associated with CSF3R Mutations or Mutations of Splicing Factor U2AF1

Hrishikesh Mehta, PhD, Hideki Maskishima, Muneyoshji Futami, MD, PhD, Wei-Ming Kao, Bartlomiej P Przychodzen, Chonghui Cheng, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, Seth J. Corey, MD, MPH

Blood (2012) 120 (21): 3792.

https://doi.org/10.1182/blood.V120.21.3792.3792

Published: 2012

Journal Articles

Bioimaging of Vascular Microenvironment Reveals Presence of Fli1a, Not VEGFR2, in Acute Lymphoblastic Leukemia Model in Syngeneic Zebrafish

Sergei Revskoy, MD, PhD, Igor Mizgirev, PhD, Seth J. Corey, MD, MPH

Blood (2011) 118 (21): 2551.

https://doi.org/10.1182/blood.V118.21.2551.2551

Published: 2011

Journal Articles

SHIP1 Is a Novel Tumor Suppressor in Late-Stage Myelodysplastic Syndromes and Is Silenced by Mir-210 and Mir-155.

Daniel W. Lee, MD, Carlos E. Bueso-Ramos, MD, Martin Carroll, MD, Zak Whichard, BA, Yanming Feng, PhD, Peter Stein, Samuel A. Jensen, BS, Steven M. Kornblau, MD, Seth J. Corey, MD, MPH

Blood (2009) 114 (22): 3824.

https://doi.org/10.1182/blood.V114.22.3824.3824

Published: 2009

Journal Articles

Abnormal PI 3-Kinase Activity Due to Increased Lyn with Decreased PTEN and Absent SHIP in Bone Marrow Cells from Patients with Myelodysplastic Syndromes.

Daniel W. Lee, MD, Quan-Sheng Zhu, MD, PhD, Sonali Rudra, BS, Elizabeth J. Shpall, MD, Steven Kornblau, MD, Seth J. Corey, MD, MPH

Blood (2005) 106 (11): 3446.

https://doi.org/10.1182/blood.V106.11.3446.3446

Published: 2005

Journal Articles

Disturbed Regulation and Activity of PI 3-Kinase Activity Due to Enhanced Lyn Kinase but Decreased Ship-1 and Gab2 Levels in Patients with Myelodysplastic Syndrome.

Daniel W. Lee, MD, Quan-Sheng Zhu, MD, PhD, Gus Zamora, BS, Ogonna Nwawka, BS, Elizabeth J. Shpall, MD, Steven K. Kornblau, MD, Seth J. Corey, MD, MPH

Blood (2004) 104 (11): 3423.

https://doi.org/10.1182/blood.V104.11.3423.3423

Published: 2004

Journal Articles

The Dual SRC/ABL Kinase Inhibitor BMS-354825 Potently Inhibits the Growth of Myeloid Leukemic Cells Characterized by FLT3-ITD Expression, GM-CSF Dependency, or G-CSF Responsiveness Via an ABL-Independent Mechanism.

Jukka Kanerva, MD, PhD, Ogonna Nwawka, BS, Kevin Hwang, Francis Y. Lee, PhD, Seth J. Corey, MD, MPH

Blood (2004) 104 (11): 4480.

https://doi.org/10.1182/blood.V104.11.4480.4480

Published: 2004

NARROW

Mutations in the Splicosome Lead to Alternative Splicing of CSF3R in Promoting Myelodysplastic Syndromes

Genetic Ablation of Sbds in Zebrafish Results in Neutropenia, Diminished Growth, and Reduced Viability, Indicating Its Roles in Embryonic and Post-Embryonic Development

Specific Gtpase Dynamin Isoforms Regulate Megakaryocyte Membrane Remodeling and The Formation Of Multivesicular Bodies and Microparticles

Profound Signaling Abnormalities Due to Cytoplasmic Variants of CSF3R in Patients with Myelodysplastic/Myeloproliferative Syndromes Associated with CSF3R Mutations or Mutations of Splicing Factor U2AF1

Bioimaging of Vascular Microenvironment Reveals Presence of Fli1a, Not VEGFR2, in Acute Lymphoblastic Leukemia Model in Syngeneic Zebrafish

SHIP1 Is a Novel Tumor Suppressor in Late-Stage Myelodysplastic Syndromes and Is Silenced by Mir-210 and Mir-155.

Abnormal PI 3-Kinase Activity Due to Increased Lyn with Decreased PTEN and Absent SHIP in Bone Marrow Cells from Patients with Myelodysplastic Syndromes.

Disturbed Regulation and Activity of PI 3-Kinase Activity Due to Enhanced Lyn Kinase but Decreased Ship-1 and Gab2 Levels in Patients with Myelodysplastic Syndrome.

The Dual SRC/ABL Kinase Inhibitor BMS-354825 Potently Inhibits the Growth of Myeloid Leukemic Cells Characterized by FLT3-ITD Expression, GM-CSF Dependency, or G-CSF Responsiveness Via an ABL-Independent Mechanism.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only